All In MedTech

FDA Clearance Tracker · P230032-S002

AvertD and AvertD Buccal Sample Collection Kit

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 7, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 7, 2024

Approved

Time to decision

174 days

Received May 17, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P230032-S002
Device name
AvertD and AvertD Buccal Sample Collection Kit
Applicant location
Carlsbad, CA
Received
May 17, 2024
Decided
Nov 7, 2024
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P230032

Device type

Device class
Class III

Every decision under product code QZH

FDA's approval statement

As written in FDA's record.

Approval for the addition of the INFINITI High-Throughput System (HTS) for use in analyzing samples with the AvertD test

Source documents

Other decisions for AutoGenomics, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.